Mcmchina

Milestone Capital manages the Milestone China Opportunities Fund I, L.P., the Milestone China Opportunities Fund II, L.P., the Milestone

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Mcmchina Information

Geographic Data

Mcmchina headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Milestone Capital manages the Milestone China Opportunities Fund I, L.P., the Milestone China Opportunities Fund II, L.P., the Milestone China Opportunities Fund III, L.P. (the “Funds”), as well as the Milestone Kunshan Investment Fund, L.P. (the “RMB Fund”) which invest primarily in established high-growth companies seeking expansion or acquisition capital in China. The Funds seek to maximize medium to long term capital appreciation by making direct investments to acquire minority or majority equity stakes in those companies identified by Milestone’s investment team. The Funds’ investment size typically ranges between US$ 10 million to US$ 100 million. The RMB Fund’s investment size ranges between RMB 20 million to RMB 80 million. The Funds invest in a limited number of portfolio companies where the Milestone Capital team can dedicate significant resources to each portfolio company. Milestone Capital’s success formula is predicated on proprietary deal flows, professional due diligence, disciplined investment approach, creative structuring and proactive monitoring with a focus on value creation. Milestone Capital usually requires board representation and stringent shareholder protection commensurate with its shareholding. Milestone Capital has a strong track record in helping portfolio companies list on either domestic or foreign stock exchanges. We leverage our extensive network of advisors, industry executives, portfolio companies as well as business relationships to bring superior value-added support to our portfolio companies from both financial and strategic angles.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
9/2014 TalkingData Series B -
10/2011 Ushi Series B 3M
5/2019 No-Antibiotics Series A 2.9M
6/2014 Eden Biologics Series B 0
6/2008 Suzhou Xiexin Photovoltaic Technology Co., Ltd Series A 260M
1/2019 Jousing Medical Series A 0
8/2018 Navid Biotech Angel Round 290k
5/2015 Eden Biologics Series C 0
3/2011 The Thatched Cottage Pharmaceutical Group Venture Round -
10/2010 Ushi Series A 0
5/2019 ChainNews Angel Round -
7/2022 Breton Series C -
9/2011 Xinhua Travel Series A 23M
4/2015 Lili &a; Beauty Series B 100M
2/2016 Mallcoo Series B 3.1M
4/2004 Focus Media Series C -
8/2016 Spiriyo Angel Round 449.2k
4/2014 Kuke Music Series A 1.6M
7/2010 Nanjing Guanya Power Equipment Series B 12M
1/2019 Jiuxin Medical Series A 3M
7/2016 ASLAN Pharmaceuticals Series D 0
1/2014 Happy Industry Series A 1.6M
7/2022 Breton Series C -
5/2019 ChainNews Angel Round -
5/2019 No-Antibiotics Series A 0
1/2019 Jousing Medical Series A 0
8/2018 Navid Biotech Angel Round 0
8/2016 Spiriyo Angel Round 0
7/2016 ASLAN Pharmaceuticals Series D 0
2/2016 Mallcoo Series B 0
5/2015 Eden Biologics Series C 0
4/2015 Lili &a; Beauty Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research